US 11975056
AADC polynucleotides for the treatment of Parkinson's disease
granted A61KA61K35/76A61K38/51
Quick answer
US patent 11975056 (AADC polynucleotides for the treatment of Parkinson's disease) held by VOYAGER THERAPEUTICS, INC. expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VOYAGER THERAPEUTICS, INC.
- Grant date
- Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K35/76, A61K38/51, A61K48/005, A61P